Detail page

Knowledge Web

Person

Evelin Schröck (1961-)

Name	Evelin Schröck
Time	1961- (Date of birth and death)
Place	Deutschland
Variant	Evelin Schrock E. Schrock
Related	Universität Heidelberg. Institut für Humangenetik (1991-1994) Institut für Klinische Genetik (Dresden)
Further information	Habil.-Schr. Fachbereich Medizinische Genetik
Record type	Person
GND-Identifier	121958043
Record ID	121958043
Involved in show all Germany’s national genomDE strategy Author Correction: Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology Targeted therapy in patients with genetic tumor syndromes Aussagekraft klinischer Kriterien im Vergleich zu genomischen Daten für die Identifizierung von Krebsprädispositionssyndromen im Kindesalter Exploring the function of human-specific ARHGAP11B in chimpanzee and human brain organoids Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification Übersicht über die klinischen Merkmale des Li-Fraumeni Syndroms und die aktuelle europäische Leitlinie des ERN GENTURIS A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers Keimbahnvarianten in Präzisionsonkologie Programmen : Pan Cancer sowie Melanom & CDKN2A Kohorte des NCT/DKTK MASTER-Programms Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples Defective homologous recombination DNA repair as therapeutic target in advanced chordoma Defective homologous recombination DNA repair as therapeutic target in advanced chordoma Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance Author Correction: Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia Integrative genomic and transcriptomic analysis of leiomyosarcoma Classification of Glioblastoma Multiforme Patients Based on an Integrative Multi-Layer Finite Mixture Model System Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study Precision oncology based on omics data: the NCT Heidelberg experience Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH An unusual case of Cowden syndrome associated with ganglioneuromatous polyposis HBOC multi-gene panel testing: comparison of two sequencing centers Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53 Spectral karyotyping of human, mouse, rat and ape chromosomes – applications for genetic diagnostics and research Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway Spektrale Karyotypisierung und vergleichende genomische Hybridisierung : neue Methoden zur umfassenden Analyse chromosomaler Aberrationen in der klinisch-genetischen Diagnostik und der Tumorgenetik 3D-Voronoi Diagramme zur quantitativen Bildanalyse in der Interphase-Cytogenetik Detection of genetic imbalances in tumor genomes by fluorescence in situ hybridization with tumor genomic DNA and subregional DNA probes Micro-ISIS : Aufbau einer Datenbank für Personalcomputer zur Phänotypdiagnostik ; Vergleich und Erfahrungen mit den international eingeführten Programmen LDDB (London Dysmorphology Database) und POSSUM (Pictures of Standard Syndromes and Undiagnosed Malformations) in der humangenetischen Familienberatung

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Evelin Schröck (1961-)

Germany’s national genomDE strategy

Author Correction: Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings

Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC

Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology

Targeted therapy in patients with genetic tumor syndromes

Aussagekraft klinischer Kriterien im Vergleich zu genomischen Daten für die Identifizierung von Krebsprädispositionssyndromen im Kindesalter

Exploring the function of human-specific ARHGAP11B in chimpanzee and human brain organoids

Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology

Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

Übersicht über die klinischen Merkmale des Li-Fraumeni Syndroms und die aktuelle europäische Leitlinie des ERN GENTURIS

A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases

Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

Keimbahnvarianten in Präzisionsonkologie Programmen : Pan Cancer sowie Melanom & CDKN2A Kohorte des NCT/DKTK MASTER-Programms

Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline

Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women

Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance

Author Correction: Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia

Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia

Integrative genomic and transcriptomic analysis of leiomyosarcoma

Classification of Glioblastoma Multiforme Patients Based on an Integrative Multi-Layer Finite Mixture Model System

Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells

Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome

Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome

Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study

Precision oncology based on omics data: the NCT Heidelberg experience

Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH

An unusual case of Cowden syndrome associated with ganglioneuromatous polyposis

HBOC multi-gene panel testing: comparison of two sequencing centers

Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53

Spectral karyotyping of human, mouse, rat and ape chromosomes – applications for genetic diagnostics and research

Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway

Spektrale Karyotypisierung und vergleichende genomische Hybridisierung : neue Methoden zur umfassenden Analyse chromosomaler Aberrationen in der klinisch-genetischen Diagnostik und der Tumorgenetik

3D-Voronoi Diagramme zur quantitativen Bildanalyse in der Interphase-Cytogenetik

Detection of genetic imbalances in tumor genomes by fluorescence in situ hybridization with tumor genomic DNA and subregional DNA probes